Clinical Trial Update: Dose-Ranging Study of A006 DPI, in Adult Asthma Patients [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study evaluating A006 DPI in adults with asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Bronchospasm

Drugs mentioned

• A006 DPI

Snippet

Sponsor: Amphastar Pharmaceuticals, Inc. | Conditions: Asthma, Bronchospasm | Phase 2 | Status: COMPLETED